Microsphere-liposome complexes protect adenoviral vectors from neutralising antibody without losses in transfection efficiency, in-vitro

Journal of Pharmacy and Pharmacology

Volumn 56, Issue 11, 2004, Pages 1371-1378

  Steel, Jason C ^a   Cavanagh, Heather M A ^a   Burton, Mark A ^a   Kalle, Wouter H J ^a  

^a CHARLES STURT UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; AMINEX; BETA GALACTOSIDASE; LIPOSOME; MICROSPHERE; MICROSPHERE LIPOSOME COMPLEX; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY COMBINING SITE; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CELL INTERACTION; CELL TRANSPORT; COMPLEX FORMATION; CONJUGATION; CONTROLLED STUDY; CULTURE OPTIMIZATION; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IN VITRO STUDY;

ADENOVIRIDAE; ANTIBODY FORMATION; CELL DEATH; DRUG DELIVERY SYSTEMS; GENE THERAPY; GENETIC VECTORS; HELA CELLS; HUMANS; LIPOSOMES; MICROSPHERES; TRANSFECTION;

EID: 8144225676     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357044643     Document Type: Article

References (27)

1. Arcasoy, S. M., Latoche, J. D., Gondor, M., Pitt, B. R., Pilewski, J. M. (1997) Polycations increase the efficiency of adenovirus-mediated gene transfer to epithelial and endothelial cells in vitro. Gene Ther. 4: 32-38
2. Benihoud, K., Yeh, P., Perricaudet, M. (1999) Adenovirus vectors for gene delivery. Curr. Opin. Biotechno., 10: 440-447
3. Byk, T., Haddada, H., Vainchenker, W., Louache, F. (1998) Lipofectamine and related cationic lipids strongly improve adenoviral infection efficiency of primitive human hematopoietic cells. Hum. Gene Ther. 9: 2493-2502
4. Chillon, M., Lee, J. H., Fasbender, A., Welsh, M. J. (1998) Adenovirus complexed with polyethylene glycol and cationic lipid is shielded from neutralizing antibodies in vitro. Gene Ther. 5: 995-1002
5. Croyle, M., Anderson, D., Roessler, B., Amidon, G. (1998) Development of a highly efficient purification process for recombinant adenoviral vectors for oral gene delivery. Pharm. Dev. Technol. 3: 365-372
6. Croyle, M., Chirmule, N., Zhang, Y., Wilson J. (2002) PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver. Hum. Gene Ther. 13: 1887-1900
7. Dass, C. R., Walker, T. L., Burton, M. A. (2002) Liposomes containing cationic dimethyl dioctadecyl ammonium bromide: formulation, quality control, and lipofection efficiency. Drug Deliv. 9: 11-18
8. Engelhardt, J., Ye, X., Doranz, B., Wilson, J. (1994) Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl Acad. Sci. USA 91: 6196-6200
9. Fasbender, A., Zabner, J., Chillon, M., Moninger, T. O., Puga, A. P., Davidson, B. L., Welsh, M. J. (1997) Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo. J. Biol. Chem. 272: 6479-6489
10. Fujita, R., Ishikawa, M., Takayanagi, M., Takayanagi, Y., Sasaki, K. (2000) Enhancement of doxorubicin activity in multidrug-resistant cells by mefloquine. Methods Find. Exp. Clin. Pharmacol. 22: 281-284
11. Kaplan, J. M., Pennington, S. E., St George, J, A., Woodworth, L. A., Fasbender, A., Marshall, J., Cheng, S. H., Wadsworth, S, C., Gregory, R. J., Smith, A. E. (1998) Potentiation of gene transfer to the mouse lung by complexes of adenovirus vector and polycations improves therapeutic potential. Hum. Gene Ther. 9: 1469-1479
12. Kim, J., Lee, S., Cho, Y., Kim, Y., Lee, J. (2001) Ectopic expression of the coxsackievirus and adenovirus receptor increases susceptibility to adenoviral infection in the human cervical cancer cell line, SiHa. Biochem. Biophys. Res. Commun. 288: 240-244
13. Mack, C., Song, W., Carpenter, H., Wickham, T., Kovesdi, I., Harvey, B., Magovern, C., Isom, O., Rosengart, T., Falck-Pedersen, E., Hackett, N., Crystal, R., Mastrangeli, A. (1997) Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype. Hum. Gene Ther. 8: 99-109
14. Meunier-Durmort, C., Picart, R., Ragot, T., Perricaudet, M., Hainque, B., Forest, C. (1997) Mechanism of adenovirus improvement of cationic liposome-mediated gene transfer. Biochim. Biophys. Acta 1: 8-16
15. Mizuno, M., Ryuke, Y., Yoshida J. (2002) Cationic liposomes conjugation to recombinant adenoviral vectors containing herpes simplex virus thymidine kinase gene followed by ganciclovir treatment reduces viral antigenicity and maintains antitumor activity in mouse experimental glioma models. Cancer Gene Ther. 9: 825-829
16. Natsume, A., Mizuno, M., Ryuke, Y., Yoshida, J. (2000) Cationic liposome conjugation to recombinant adenoviral vector reduces viral antigenicity. Jpn J. Cancer Res. 91: 363-367
17. O'Riordan, C. R., Lachapelle, A., Delgado, C., Parkes, V., Wadsworth, S. C., Smith, A. E., Francis, G. E. (1999) PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo. Hum. Gene Ther. 10: 1349-1358
18. Prince, H. (1998) Gene transfer: a review of methods and applications. Pathology 30: 335-347
19. Qiu, C, De Young, M. B., Finn, A., Dichek, D. A. (1998) Cationic liposomes enhance adenovirus entry via a pathway independent of the fiber receptor and alpha(v)-integrins. Hum. Gene Ther. 9: 507-520
20. Russell, W. C. (2000) Update on adenovirus and its vectors. [Review]. J. Gen. Virol 81: 2573-2604
21. Steel, J. C., Cavanagh, H. M., Burton, M. A., Dingwall, D., Kalle, W. H. (2004) In-vitro evaluation of ion-exchange microspheres for the sustained release of liposomal-adenoviral conjugates. J. Control. Release 95: 601-611
22. St George, J. A. (2003) Gene therapy progress and prospects: adenoviral vectors. [Review], Gene Ther. 10: 1135-1141
23. Toyoda, K., Ooboshi, H., Chu, Y., Fas bender, A., Davidson, B. L., Welsh, M. J., Heistad, D. D. (1998) Cationic polymer and lipids enhance adenovirus-mediated gene transfer to rabbit carotid artery. Stroke 29: 2181-2188
24. Verma, L, Somia, N. (1997) Gene therapy - promises, problems and prospects. Nature 389: 239-242
25. Vilquin, J., Guerette, B., Kinoshita, I., Roy, B., Goulet, M., Gravel, C., Roy, R., Tremblay, J. (1995) FK 506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer. Hum. Gene Ther. 6: 1391-1401
26. Wilson, C., Embree, L., Schowalter, D., Albert, R., Aruffo, A., Hollenbaugh, D., Linsley, P., Kay, M. (1998) Transient inhibition of CD28 and CD40 ligand interactions prolongs adenovirus-mediated transgene expression in the lung and facilitates expression after secondary vector administration. J. Virol. 72: 7542-7550
27. Worgall, S., Worgall, T. S., Kostarelos, K., Singh, R., Leopold, P. L., Hackett, N. R., Crystal, R. G. (2000) Free cholesterol enhances adenoviral vector gene transfer and expression in CAR-deficient cells. Mol. Ther. 1: 39-48